Life Healthcare Group Holdings Limited

As of March 31, 2026, Life Healthcare Group Holdings Limited carries a market capitalization of 1.65T, placing it among publicly traded companies globally. Its enterprise value stands at 2.09T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Life Healthcare Group Holdings Limited's next confirmed earnings release is scheduled for November 26, 2026.

As of March 31, 2026, Life Healthcare Group Holdings Limited has 1.43B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Life Healthcare Group Holdings Limited maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Life Healthcare Group Holdings Limited's stock has gained approximately 4.58% over the past 52 weeks. The 50-day moving average sits at 1,186.86, while the 200-day moving average is 1,141.83.

As of March 31, 2026, Life Healthcare Group Holdings Limited holds 113.10B in cash and equivalents against 481.40B in total debt, resulting in a net debt position of -113.10B. Total book value stands at 1.13T, with working capital of 186.40B providing operational flexibility.

Life Healthcare Group Holdings Limited's most recent stock split took place on March 29, 2017 with a 254:273 split ratio.